T3011: Clinical Trials

6 trials of T3011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown. 6 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Recruiting 3, Unknown 3
Phase 15Unknown 3, Recruiting 2

Follow T3011: new trials by email Literature Review of T3011 trials Research Report on T3011

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
T3011 - Nonmuscle-invasive Bladder Cancer
Phase 2RecruitingImmVira Pharma Co. Ltd1602025-06-092026-08-18
A Clinical Study of T3011 in Subjects With Advanced Melanoma
T3011 - Advanced Melanoma
Phase 1 / Phase 2RecruitingShanghai Pharmaceuticals Holding Co., Ltd422024-01-262026-08-06
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
T3011 - Advanced Solid Tumor, Lung Cancer
Phase 1 / Phase 2UnknownImmVira Pharma Co. Ltd742022-03-012022-10-28
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
T3011 - Solid Tumor, Hepatocellular Carcinoma
Phase 1 / Phase 2UnknownImmVira Pharma Co. Ltd422021-08-102024-03-04
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
T3011, T3011 + pembrolizumab - Solid Tumor, Melanoma
Phase 1 / Phase 2RecruitingImmVira Pharma Co. Ltd302020-09-172025-10-08
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
T3011 - Advanced Solid Tumor, Sarcoma
Phase 1 / Phase 2UnknownImmVira Pharma Co. Ltd2332020-04-212022-11-02

Conditions studied

Sarcoma (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Mesothelioma, Malignant (1)  ·  Ovarian Neoplasms (1)

Sponsors

ImmVira Pharma Co. Ltd (5)  ·  Shanghai Pharmaceuticals Holding Co., Ltd (1)

Countries

China (3)  ·  United States (3)  ·  Australia (1)

Results publications

PMID 41721376